Switching from Neutral Protamine Hagedorn (NPH) Insulin to Insulin Glargine 300 U/mL in Older and Younger Patients with Type 2 Diabetes: A Post Hoc Analysis of a Multicenter, Prospective, Observational Study

被引：0
|
作者：
B. Wolnik
A. Hryniewiecki
D. Pisarczyk-Wiza
T. Szczepanik
T. Klupa
机构：
[1] Medical University of Gdańsk,Department of Hypertension and Diabetology
[2] Sanofi-Aventis Poland,Diabetes Division
[3] Medical University of Poznan,Department of Internal Diseases and Diabetology
[4] Starkiewicz Hospital,Zaglebie Oncology Center
[5] Jagiellonian University Medical College,Department of Metabolic Diseases
来源：
Diabetes Therapy | 2022年 / 13卷
关键词：
Type 2 diabetes; Elderly; Hypoglycemia; Insulin; NPH; Glargine 300;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：301 / 310
页数：9
相关论文
共 50 条
  • [41] Improved treatment satisfaction in patients with type 1 diabetes treated with insulin glargine 100 U/mL versus neutral protamine Hagedorn insulin: An exploration of key predictors from two randomized controlled trials
    Polonsky, William
    Traylor, Louise
    Gao, Ling
    Wei, Wenhui
    Ameer, Barbara
    Stuhr, Andreas
    Vlajnic, Aleksandra
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (03) : 562 - 568
  • [42] Switching to insulin glargine 300 units/mL in real-world older patients with type 2 diabetes (DELIVER 3)
    Bailey, Timothy S.
    Wu, Jasmanda
    Zhou, Fang L.
    Gupta, Rishab A.
    Menon, Arjun A.
    Berhanu, Paulos
    Westerbacka, Jukka
    Van Vleet, John
    Blonde, Lawrence
    DIABETES OBESITY & METABOLISM, 2019, 21 (11): : 2384 - 2393
  • [43] Insulin glargine compared to neutral protamine Hagedorn (NPH) insulin in patients with type-2 diabetes uncontrolled with oral anti-diabetic agents alone in Hong Kong: a cost-effectiveness analysis
    E. Lau
    A. Salem
    J. C. N. Chan
    W. Y. So
    A. Kong
    M. Lamotte
    A. Luk
    Cost Effectiveness and Resource Allocation, 17
  • [44] Comparison of Incidence of Acute Myocardial Infarction in Patients With Type 2 Diabetes Mellitus Following Initiation of Neutral Protamine Hagedorn Insulin Versus Insulin Glargine
    Rhoads, George G.
    Kosiborod, Mikhail
    Nesto, Richard W.
    Fonseca, Vivian A.
    Lu, Shou-En
    Zhang, Quanwu
    Foody, Joanne M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (07): : 910 - 916
  • [45] Insulin glargine compared to neutral protamine Hagedorn (NPH) insulin in patients with type-2 diabetes uncontrolled with oral anti-diabetic agents alone in Hong Kong: a cost-effectiveness analysis
    Lau, E.
    Salem, A.
    Chan, J. C. N.
    So, W. Y.
    Kong, A.
    Lamotte, M.
    Luk, A.
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2019, 17 (1)
  • [46] A cross-sectional study of the quality of life of patients living with type 1 diabetes treated with insulin glargine and neutral protamine Hagedorn insulin and the implications
    Almeida, Paulo H. R. F.
    Godman, Brian
    de Lemos, Livia L. P.
    Silva, Thales B. C.
    Acurcio, Francisco de Assis
    Guerra-Junior, Augusto Afonso
    de Araujo, Vania E.
    Almeida, Alessandra M.
    Alvares-Teodoro, Juliana
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2021, 12 (03) : 332 - 342
  • [47] Switching to insulin glargine 300 U/ml in patients with type 2 diabetes on basal insulin supported oral therapy (BOT) improves glycaemic control
    Seufert, J.
    Fritsche, A.
    Anderten, H.
    Pegelow, K.
    Pscherer, S.
    Pfohl, M.
    DIABETOLOGIA, 2018, 61 : S441 - S441
  • [48] Treatment responses to basal insulin glargine 300 U/ml and glargine 100 U/ml in newly defined subphenotypes of type 2 diabetes: A post hoc analysis of the EDITION 3 randomized clinical trial
    Landgraf, Wolfgang
    Owens, David R.
    Frier, Brian M.
    Bolli, Geremia B.
    DIABETES OBESITY & METABOLISM, 2024, 26 (02): : 503 - 511
  • [49] The effectiveness of insulin glargine 300 U/ml among type 2 diabetes patients: analysis of a real world data
    Cohen, C. Melzer
    Shalev, V.
    Chodick, G.
    DIABETOLOGIA, 2019, 62 : S436 - S437
  • [50] Glycemic Control in People with Type 2 Diabetes (PWT2D) Switching from NPH to Insulin Glargine 300 U/mL (Gla-300) : REALI Pooled Database
    Mueller-Wieland, Dirk
    Freemantle, Nick
    Bonadonna, Riccardo C.
    Mauquoi, Celine
    Bigot, Gregory
    Bonnemaire, Mireille
    Gourdy, Pierre
    Mauricio, Didac
    DIABETES, 2022, 71
12345